The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eat more plants for influenza resilience: Antibiotic treatment worsens influenza in mice, possibly because the concomitant loss of the microbiota interrupts the production of bioactive metabolites. Steed et al. found that a microbial product, desaminotyrosine (DAT), produced by an obligate clostridial anaerobe from the digestion of plant flavonoids, is beneficial during influenza. DAT enters the bloodstream and triggers type I interferon signaling, which then augments antiviral responses by phagocytic cells. Without DAT, influenza virus causes inflammation and severe disease. Science , this issue p. 498
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.220”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [220]
In the citing paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.(220) Additionally, recent evidence points towards a potential of a locally entrenched lung microbiota possibly impacting pulmon…”
BackgroundShared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 876
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aar6918 · Cited by 777
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
“produced by clostridium orbiscindens protects mice from influenza through augmentation of IFN-I signaling [39].”
BackgroundPolyphenols and their applications: An approach in food chemistry and innovation potential
de Araújo, F. F., de Paulo Farias, D., Neri-Numa, I. A., & Pastore, G. M. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2020.127535 · Cited by 600
The influence of the microbiome on respiratory health
Wypych, T. P., Wickramasinghe, L. C., & Marsland, B. J. (2019) · Nature Immunology · doi:10.1038/s41590-019-0451-9 · Cited by 611
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Lam, K. C., Araya, R. E., Huang, A., Chen, Q., Di Modica, M., Rodrigues, R. R., Lopès, A., Johnson, S. B., Schwarz, B., Bohrnsen, E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.019 · Cited by 604
Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602
Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia.
Hanada, S., Pirzadeh, M., Carver, K. Y., & Deng, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02640 · Cited by 495
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality (59).”
BackgroundAbsorption, metabolism and bioavailability of flavonoids: a review
Chen, L., Cao, H., Huang, Q., Xiao, J., & Teng, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1917508 · Cited by 430
“The binding reactions of flavonoids in liver mainly include glucuronization, sulfation and methylation (Steed et al. 2017).”
BackgroundAntunes, K. H., Fachi, J. L., de Paula, R., da Silva, E. F., Pral, L. P., dos Santos, A. Á., Dias, G. B. M., Vargas, J. E., Puga, R., Mayer, F. Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11152-6 · Cited by 385
Sencio, V., Barthelemy, A., Tavares, L. P., Machado, M. G., Soulard, D., Cuinat, C., Queiroz-Junior, C. M., Noordine, M.-L., Salomé-Desnoulez, S., Deryuter, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.013 · Cited by 357
“It has recently been shown that a healthy microbiota has a critical role in the host’s defense against respiratory tract infections, including IAV (Abt et al., 2012; Bradley et al., 2019; Ichinohe et al., 2011; Moriyama and Ichinohe, 2019; Steed et al., 2017) and S.”
The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis
Erttmann, S. F., Swacha, P., Aung, K. M., Brindefalk, B., Jiang, H., Härtlova, A., Uhlin, B. E., Wai, S. N., & Gekara, N. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.006 · Cited by 350
Tumilaar, S. G., Hardianto, A., Dohi, H., & Kurnia, D. (2024) · Journal of Chemistry · doi:10.1155/2024/5594386 · Cited by 265
Zhang, Y., Tu, S., Ji, X., Wu, J., Meng, J., Gao, J., Shao, X., Shi, S., Wang, G., Qiu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45636-x · Cited by 311
Wang, M., Firrman, J., Liu, L., & Yam, K. (2019) · BioMed Research International · doi:10.1155/2019/7010467 · Cited by 320
“This degradation product 3-(4-hydroxyphenyl)propionic acid, also known as desaminotyrosine (DAT) is beneficial during influenza by triggering type I interferon signaling and in turn augmenting antiviral responses by phagocytic cells; therefore preventing inflammation and severe disease [133].”
BackgroundSencio, V., Machado, M. G., & Trottein, F. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00361-8 · Cited by 311
Bradley, K. C., Finsterbusch, K., Schnepf, D., Crotta, S., Llorian, M., Davidson, S., Fuchs, S. Y., Staeheli, P., & Wack, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.105 · Cited by 313
“Mice treated with oral antibiotics are more susceptible to viral infections, including influenza A virus (Abt et al., 2012; Goulding et al., 2011; Ichinohe et al., 2011; Oh et al., 2016; Steed et al., 2017), partly by regulating the activation threshold of the immune response.”
BackgroundMining the microbiota for microbial and metabolite-based immunotherapies
Skelly, A. N., Sato, Y., Kearney, S., & Honda, K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0144-5 · Cited by 306
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
“Similarly, Clostridium orbiscindens, a human intestinal bacterium, and its derived metabolite desaminotyrosine (DAT), has rescued mice infected with influenza virus through modulation of type I IFN signaling (Steed et al., 2017).”
BackgroundThe Commensal Microbiota and Viral Infection: A Comprehensive Review
Li, N., Ma, W.-T., Pang, M., Fan, Q.-L., & Hua, J.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01551 · Cited by 283
Flavonoids and the gastrointestinal tract: local and systemic effects
Oteiza, P. I., Fraga, C. G., Mills, D. A., & Taft, D. H. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.001 · Cited by 281
Haak, B. W., Littmann, E. R., Chaubard, J.-L., Pickard, A. J., Fontana, E., Adhi, F., Gyaltshen, Y., Ling, L., Morjaria, S. M., Peled, J. U., et al. (2018) · Blood · doi:10.1182/blood-2018-01-828996 · Cited by 273
Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells
Schaupp, L., Muth, S., Rogell, L., Kofoed-Branzk, M., Melchior, F., Lienenklaus, S., Ganal-Vonarburg, S. C., Klein, M., Guendel, F., Hain, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.022 · Cited by 263
Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 251
Simpson, R. C., Shanahan, E. R., Batten, M., Reijers, I. L. M., Read, M., Silva, I. P., Versluis, J. M., Ribeiro, R., Angelatos, A. S., Tan, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01965-2 · Cited by 256
Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention
von Mutius, E., & Smits, H. H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31861-4 · Cited by 220
Wang, P., Gao, J., Ke, W., Wang, J., Li, D., Liu, R., Jia, Y., Wang, X., Chen, X., Chen, F., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.013 · Cited by 231
Zhang, F., Wan, Y., Zuo, T., Yeoh, Y. K., Liu, Q., Zhang, L., Zhan, H., Lu, W., Xu, W., Lui, G. C. Y., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.013 · Cited by 234
“Metabolites secreted by gut microbiome (such as tyrosine) could protect from influenza through the production of type I interferons and inflammasome-dependent cytokines by pulmonary cells.(13,14) Whether microbial-derived metabolites also regulate host immune response to SARS-CoV-2 infections remains unknown.”
BackgroundBernard-Raichon, L., Venzon, M., Klein, J., Axelrad, J. E., Zhang, C., Sullivan, A. P., Hussey, G. A., Casanovas-Massana, A., Noval, M. G., Valero-Jimenez, A. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33395-6 · Cited by 223
Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice
Jain, U., Ver Heul, A. M., Xiong, S., Gregory, M. H., Demers, E. G., Kern, J. T., Lai, C.-W., Muegge, B. D., Barisas, D. A. G., Leal-Ekman, J. S., et al. (2021) · Science · doi:10.1126/science.abd0919 · Cited by 218
Self-citationEndogenous retroviruses promote homeostatic and inflammatory responses to the microbiota
Lima-Junior, D. S., Krishnamurthy, S. R., Bouladoux, N., Collins, N., Han, S.-J., Chen, E. Y., Constantinides, M. G., Link, V. M., Lim, A. I., Enamorado, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.020 · Cited by 196
Viana, S. D., Nunes, S., & Reis, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101123 · Cited by 185
“Accordingly, a microbial-derived metabolite produced by the human-associated commensal gut bacteria Clostridium orbiscendens – desaminotyrosine – was able to protect mice from lethal Influenza Virus infection, presumably due to the vigorous priming and amplification of type I IFN-dependent antiviral immune response (S…”
Winkler, E. S., Shrihari, S., Hykes, B. L., Handley, S. A., Andhey, P. S., Huang, Y.-J. S., Swain, A., Droit, L., Chebrolu, K. K., Mack, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.029 · Cited by 193
“The following primers were used for PCR- based amplification (Steed et al., 2017; Wells et al., 2003; Yuli et al., 2005): baiCD forward (5′-GGWTTCAGCCCRCAGATGTTCTTTG-3′), baiCD reverse (5′-GAATTCCGGGTTCATGAACATTCTKCKAAG-3′; C.”
InfluentialSelf-citationWang, B., Zhang, L., Wang, Y., Dai, T., Qin, Z., Zhou, F., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00986-0 · Cited by 184
“It was recently demonstrated that DAT protects the host from influenza infection by initiating a type I interferon (IFN) signaling amplification loop.(145) The authors used a reporter cell line harboring multiple type I IFN response elements to screen a library of 84 microbe-associated metabolites and found that DAT s…”
BackgroundBioactive natural compounds against human coronaviruses: a review and perspective
Xian, Y., Zhang, J., Bian, Z., Zhou, H., Zhang, Z., Lin, Z., & Xu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.002 · Cited by 177
Mu, H., Zhou, Q., Yang, R., Zeng, J., Li, X., Zhang, R., Tang, W., Li, H., Wang, S., Shen, T., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.585066 · Cited by 176
Liu, T.-C., Kern, J. T., Jain, U., Sonnek, N. M., Xiong, S., Simpson, K. F., VanDussen, K. L., Winkler, E. S., Haritunians, T., Malique, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.004 · Cited by 170
Self-citationMicrobiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170
Gut microbiota: A new insight into lung diseases
Ma, P.-J., Wang, M.-M., & Wang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113810 · Cited by 163
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
Danlos, F.-X., Grajeda-Iglesias, C., Durand, S., Sauvat, A., Roumier, M., Cantin, D., Colomba, E., Rohmer, J., Pommeret, F., Baciarello, G., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03540-y · Cited by 168
Nutrient-rich bee pollen: A treasure trove of active natural metabolites
Li, Q., Wang, K., Marcucci, M. C., Sawaya, A. C. H. F., Hu, L. T., Xue, X., Wu, L., & Hu, F. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.008 · Cited by 166
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis
Haak, B. W., Prescott, H. C., & Wiersinga, W. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02042 · Cited by 159
“Besides short-chain fatty acids, it has also been found that desamonityrosine (DAT), a degradation product of flavonoids that is produced by Flavonifractor plautii, increases survival in mice infected with influenza through augmentation of type I interferon (IFN) signaling (37).”
BackgroundWitjes, J. J., Smits, L. P., Pekmez, C. T., Prodan, A., Meijnikman, A. S., Troelstra, M. A., Bouter, K. E. C., Herrema, H., Levin, E., Holleboom, A. G., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1601 · Cited by 153
“Moreover, ARHGAP18 was inversely correlated with plasma desaminotyrosine levels, a microbial metabolite that is known to trigger IFN1.”
BackgroundThe gut–airway microbiome axis in health and respiratory diseases
Özçam, M., & Lynch, S. V. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01048-8 · Cited by 172
“For example, the gut microbial-derived metabolite desaminotyrosine, produced through flavonoid metabolism, promotes protective airway innate immunity against influenza virus infection by enhancing the interferon-regulated responses of pulmonary phagocytes, which are key to viral clearance 88 .”
Early Life Microbiota and Respiratory Tract Infections
Piters, W. A. A. D. S., Binkowska, J. M., & Bogaert, D. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.004 · Cited by 169
Gheorghe, C. E., Ritz, N. L., Martin, J. A., Wardill, H. R., Cryan, J. F., & Clarke, G. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941711 · Cited by 148
Gut-Lung Crosstalk in Sepsis-Induced Acute Lung Injury
Zhou, X., & Liao, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.779620 · Cited by 153
“Phenolic One of the degradation products of flavonoids and amino acids by commensal bacteria is desaminotyrosine (DAT; Steed et al., 2017).”
BackgroundStructural insights and biological activities of flavonoids: Implications for novel applications
Tang, S., Wang, B., Liu, X., Xi, W., Yue, Y., Tan, X. S., Bai, J., & Huang, L. (2024) · Food Frontiers · doi:10.1002/fft2.494 · Cited by 164
Gut microbiota-derived metabolites tune host homeostasis fate
Kim, S., Seo, S., & Kweon, M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01012-x · Cited by 169
“…orbiscindens in the human gut, such as desaminotyrosine, protect against respiratory virus infection by activating type-I IFN in macrophage [149], while glycolipids associated with Bacteroides fragilis confer resistance to vesicular stomatitis virus and influenza virus by type-I IFN…”
BackgroundZhang, Q., Jin, H., Feng, J., Hu, X., Wang, T., Gong, W., Huang, K. L., Guo, Y., Zou, Z., Xian, L., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02007-1 · Cited by 163
“Further, microbial metabolites, such as desaminotyrosine, exert a protective effect against influenza via interferon I signaling [10].”
BackgroundInfluentialHaak, B. W., Westendorp, W. F., van Engelen, T. S. R., Brands, X., Brouwer, M. C., Vermeij, J., Hugenholtz, F., Verhoeven, A., Derks, R. J. E., Giera, M. A., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00863-4 · Cited by 155
“bacteria could be an uncharted marker of immunological resilience that extends beyond the effects of butyrate alone [44].”
BackgroundMicrobiome dysbiosis in lung cancer: from composition to therapy
Liu, N., Ma, Q., Ge, Y., Yi, C., Wei, L., Tan, J.-C., Chu, Q., Li, J., Zhang, P., & Wang, H. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-00138-z · Cited by 156
Kim, S. M., DeFazio, J. R., Hyoju, S. K., Sangani, K., Keskey, R., Krezalek, M. A., Khodarev, N. N., Sangwan, N., Christley, S., Harris, K. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15545-w · Cited by 136
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection
Trottein, F., & Sokol, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107915 · Cited by 156
“In the setting of influenza infections, the results of experiments with antibiotic treatment (to deplete the residual microbiota) have demonstrated that the gut microbiota is critical for controlling viral replication (Ichinohe et al., 2011; Abt et al., 2012; Steed et al., 2017; Bradley et al., 2019).”
Integrated gut virome and bacteriome dynamics in COVID-19 patients
Cao, J., Wang, C., Zhang, Y., Lei, G., Xu, K., Zhao, N., Lu, J., Meng, F., Yu, L., Yan, J., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1887722 · Cited by 151
Microbiota-derived acetate enhances host antiviral response via NLRP3
Niu, J., Cui, M., Yang, X., Li, J., Yao, Y., Guo, Q., Lu, A., Qi, X., Zhou, D., Zhang, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36323-4 · Cited by 154
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
He, L.-H., Ren, L.-F., Li, J.-F., Wu, Y.-N., Li, X., & Zhang, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01388 · Cited by 124
High ambient temperature dampens adaptive immune responses to influenza A virus infection
Moriyama, M., & Ichinohe, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815029116 · Cited by 133
“Consistent with their beneficial effects on antiviral immunity, recent studies highlight the importance of microbiota-derived metabolites in protection against influenza virus infection (19, 20).”
BackgroundGut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis
Su, X., Zhao, Y., Li, Y., Ma, S., & Wang, Z. (2020) · Clinical Science · doi:10.1042/cs20200475 · Cited by 149
Akkermansia muciniphila protects mice against an emerging tick-borne viral pathogen
Xie, J., Li, H., Zhang, X., Yang, T., Yue, M., Zhang, Y., Chen, S., Cui, N., Yuan, C., Li, J., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01279-6 · Cited by 137
Grau, K. R., Zhu, S., Peterson, S. T., Helm, E. W., Philip, D. T., Phillips, M. B., Hernandez, A., Turula, H., Frasse, P., Graziano, V. R., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0602-7 · Cited by 135
Microplastics as an aquatic pollutant affect gut microbiota within aquatic animals
Li, W., Chen, X., Li, M., Cai, Z., Gong, H., & Yan, M. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127094 · Cited by 128
The path toward using microbial metabolites as therapies
Descamps, H. C., Herrmann, B., Wiredu, D., & Thaiss, C. A. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.063 · Cited by 123
“A recent study showed that an intact gut microbiome, and in particular the presence of Clostridium orbiscendens, is required for detectable DAT levels in the feces and serum [83].”
BackgroundCelorrio, M., Abellanas, M. A., Rhodes, J., Goodwin, V. M., Moritz, J., Vadivelu, S., Wang, L., Rodgers, R., Xiao, S., Anabayan, I., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01137-2 · Cited by 127
Self-citationDiscovery of an ene-reductase for initiating flavone and flavonol catabolism in gut bacteria
Yang, G., Hong, S., Yang, P., Sun, Y.-W., Wang, Y., Zhang, P., Jiang, W., & Gu, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-20974-2 · Cited by 126
de Reuver, R., Dierick, E., Wiernicki, B., Staes, K., Seys, L., Meester, E. D., Muyldermans, T., Botzki, A., Lambrecht, B. N., Nieuwerburgh, F. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109500 · Cited by 126
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 138
Gut Microbiota Status in COVID-19: An Unrecognized Player?
Zeppa, S. D., Agostini, D., Piccoli, G., Stocchi, V., & Sestili, P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576551 · Cited by 125
“A healthy microbiota can counteract respiratory tract infection including the influenza A virus (IAV) (Steed and Christophi, 2017; Bradley et al., 2019; Moriyama and Ichinohe, 2019) and Streptococcus pneumonia (Schuijt et al., 2016), modulating the functions of effector immune cells, including alveolar macrophages and…”
BackgroundThe Baseline Gut Microbiota Directs Dieting-Induced Weight Loss Trajectories
Jie, Z., Yu, X., Liu, Y., Sun, L., Chen, P., Ding, Q., Gao, Y., Zhang, X., Yu, M., Liu, Y., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.029 · Cited by 116
Self-citationImmune-Microbiota Interplay and Colonization Resistance in Infection
Leshem, A., Liwinski, T., & Elinav, E. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.001 · Cited by 128
He, Y., Wang, J., Li, F., & Shi, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01302 · Cited by 114
Costa, M., Bayındır, Z. S., Losada‐Barreiro, S., Paiva‐Martins, F., Saso, L., & Bravo‐Díaz, C. (2021) · Biomedicines · doi:10.3390/biomedicines9121909 · Cited by 124
“Moreover, the presence of antioxidants seems to modulate the existing microbiota, suggesting their application in foods as probiotics [91].”
BackgroundMicrobiota regulation of viral infections through interferon signaling
Wirusanti, N. I., Baldridge, M. T., & Harris, V. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.01.007 · Cited by 119
“Administration of DAT into mice infected with influenza A virus protected mice from infection-associated mortality and morbidity but did not reduce viral titers [52].”
BackgroundInfluentialde Almeida, V. M., Galvão, I., & Vieira, A. T. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2019.0011 · Cited by 119
The microbiota in pneumonia: From protection to predisposition
Thibeault, C., Suttorp, N., & Opitz, B. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba0501 · Cited by 113
Nurturing the Early Life Gut Microbiome and Immune Maturation for Long Term Health
Dogra, S. K., Chung, C. K. C. K., Wang, D., Sakwińska, O., Mottaz, S. C., & Sprenger, N. (2021) · Microorganisms · doi:10.3390/microorganisms9102110 · Cited by 116
“Several microbial produced metabolites, such as desaminotyrosine (DAT), promote the induction of type I interferon responses, which protect mice against influenza infection and decrease infection-mediated lung immunopathology [88].”
BackgroundClinical translation of microbiome research
Gilbert, J. A., Azad, M. B., Bäckhed, F., Blaser, M. J., Byndloss, M. X., Chiu, C. Y., Chu, H., Dugas, L. R., Elinav, E., Gibbons, S. M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03615-9 · Cited by 123
Skalski, J. H., Limon, J. J., Sharma, P., Gargus, M. D., Nguyen, C., Tang, J., Coelho, A. L., Hogaboam, C. M., Crother, T. R., & Underhill, D. M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007260 · Cited by 105
Gut Microbiota, in the Halfway between Nutrition and Lung Function
Santo, C. E., Caseiro, C., Martins, M. J., Monteiro, R., & Brandão, I. (2021) · Nutrients · doi:10.3390/nu13051716 · Cited by 111
“DAT, a product generated by the gut commensal Clostridium orbiscindens during flavonoid metabolism, augments type I IFN signalling with a consequent reduction of lung immunopathology (less airway epithelial damage and apoptosis) during influenza virus infection [72].”
BackgroundWegorzewska, M. M., Glowacki, R. W. P., Hsieh, S. A., Donermeyer, D. L., Hickey, C. A., Horvath, S. C., Martens, E. C., Stappenbeck, T. S., & Allen, P. M. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9079 · Cited by 107
Self-citationEnzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer
AL-Ishaq, R. K., Líšková, A., Kubatka, P., & Büsselberg, D. (2021) · Cancers · doi:10.3390/cancers13163934 · Cited by 110
“3-(4-hydroxyphenyl) propionic acid is beneficial during infection with influenzas triggering interferon type 1 pathway and preventing inflammation [86].”
BackgroundInterferons in health and disease
Boehmer, D. F. R., & Zanoni, I. (2025) · Cell · doi:10.1016/j.cell.2025.06.044 · Cited by 119
Microbiota and Its Role on Viral Evasion: Is It With Us or Against Us?
Domínguez-Díaz, C., García-Orozco, A., Leal, A. R., Padilla-Arellano, J. R., & Fafutis‐Morris, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00256 · Cited by 109
Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease
Gounder, A. P., & Boon, A. C. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801010 · Cited by 108
“Ex vivo, CD4+, and CD8+ T cells from overweight and obese individuals expressed lower levels of CD69, CD28, and CD40L, as well as the effector molecules IFN-g and granzyme B, suggesting deficiencies in activation following stimulation with IAV (87).”
BackgroundInfluentialSelf-citationMetabolic Adaptations to Infections at the Organismal Level
Troha, K., & Ayres, J. S. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.001 · Cited by 97
“Recently, it has become evident that metabolite-conferred protection can sometimes be attributed to the presence of a single bacterial species with rare biosynthetic capacity within the host (16, 17).”
BackgroundBovine respiratory microbiota of feedlot cattle and its association with disease
Chai, J., Capik, S. F., Kegley, B., Richeson, J. T., Powell, J. G., & Zhao, J. (2022) · Veterinary Research · doi:10.1186/s13567-021-01020-x · Cited by 87
“[115] reported a microbially produced metabolite in humans (desaminotyrosine) that can protect the host by amplifying type I IFN signaling.”
BackgroundBiology of human milk oligosaccharides: From basic science to clinical evidence
Sprenger, N., Tytgat, H. L. P., Binia, A., Austin, S., & Singhal, A. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12990 · Cited by 104
“from respiratory viral infections through immune active microbial metabolites.(86,161) Together, an intricate interplay between different breast milk glycan structures, including free HMOs, the gut microbiome and specific pathogens, is expected.”
BackgroundThe microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Perdijk, O., Azzoni, R., & Marsland, B. J. (2023) · Physiological Reviews · doi:10.1152/physrev.00020.2023 · Cited by 105
Microbiome diurnal rhythmicity and its impact on host physiology and disease risk
Nobs, S. P., Tuganbaev, T., & Elinav, E. (2019) · EMBO reports · doi:10.15252/embr.201847129 · Cited by 90
“, through boosting of type I interferon signaling [103], both in the intestinal tract and in peripheral organs.”
Li, Y., Su, X., Gao, Y., Lv, C., Gao, Z., Liu, Y., Wang, Y., Li, S., & Wang, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165764 · Cited by 102
Gut microbiota and systemic immunity in health and disease
Lo, B. C., Chen, G., Núñez, G., & Caruso, R. (2020) · International Immunology · doi:10.1093/intimm/dxaa079 · Cited by 93
Sencio, V., Machelart, A., Robil, C., Benech, N., Hoffmann, E., Galbert, C., Deryuter, L., Heumel, S., Hantute-Ghesquier, A., Flourens, A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2018900 · Cited by 93
“These immune stimulatory sources include acetate, desaminotyrosine (degradation product of flavonoids) and indole derivatives (produced by tryptophan metabolism).(48,75,76) Along with these antiviral effects, gut-derived bacteria and components might also reduce acute inflammation and organ failure, impact on long COV…”
BackgroundLiu, Y., Chen, H., Van Treuren, W., Hou, B.-H., Higginbottom, S. K., & Dodd, D. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01109-9 · Cited by 89
Reinold, J., Farahpour, F., Fehring, C., Dolff, S., Konik, M., Korth, J., van Baal, L., Hoffmann, D. E., Buer, J., Witzke, O., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.747816 · Cited by 92
“The gut microbiota influences the outcome of infectious lung diseases in animal models (Schuijt et al., 2016; Steed et al., 2017) and vice versa, pulmonary infections affect the gut microbiota (Wang et al.”
BackgroundThe Unique Microbiome and Innate Immunity During Pregnancy
Mei, C., Yang, W., Wei, X., Wu, K., & Huang, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02886 · Cited by 86
“so on, then causes the secretion of diversity anti-inflammatory factors that activate specific immune cells; (3) The defensive role of syncytiotrophoblast is mainly from”
BackgroundInfluentialReview of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 95
“The metabolites produced by Clostridium orbiscindens can alleviate the invasion of in fl uenza in mice by enhancing IFN-I pathway (Steed et al., 2017).”
BackgroundVillena, J., & Kitazawa, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00699 · Cited by 86
Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis
Ji, J., Sun, Q., Nie, D., Wang, Q., Zhang, H., Qin, F., Wang, Q.-S., Lu, S.-F., Pang, G., & Lu, Z. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00573-5 · Cited by 86
Metadata
- Authors
- Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., Boon, A. C. M., Lenschow, D. J., & Stappenbeck, T. S.
- Affiliations
- Washington University in St. Louis (US)
- ITMO University (RU)
- Corresponding author
- Stappenbeck, Thaddeus S.
- ORCID
- Venue
- Science
- Published
- 2017-08-04
- Volume
- 357
- Issue
- 6350
- Pages
- 498-502
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5753406
- OpenAlex
- W2743370588
- Cited by
- 569
- References
- 55
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 68 · 2023: 74 · 2022: 80 · 2021: 94 · 2020: 78 · 2019: 37 · 2018: 29 · 2017: 8
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Crohn’s Colitis (award312855)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Keywords
- influenza, type I interferon, gut microbiota, microbial metabolites, plant flavonoids, Clostridium, antibiotic-induced dysbiosis, antiviral immunity, phagocytes, inflammation, plant-based diet
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Line, Clostridium perfringens, Interferon Type I, Lung, Orthomyxoviridae Infections, Phenylpropionates, Signal Transduction, Mice, Knockout, GTP-Binding Proteins, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.